PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-May-2022 New programme celebrates ChargePoint Technology's role in COVID-19 vaccine rollout ChargePoint Technology
10-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-May-2022 Recuro Health Awarded as Technology Pioneer by World Economic Forum Businesswire
10-May-2022 EMQ Awarded as Technology Pioneer by World Economic Forum Businesswire
10-May-2022 FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets Businesswire
10-May-2022 Sygnature Discovery to Deploy Iktos’s AI for Drug Design Software Makya™ Businesswire
10-May-2022 TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation Businesswire
10-May-2022 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022 Businesswire
10-May-2022 InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization Newswire
10-May-2022 Monrol Is Partnering With Telix Pharmaceuticals, Supplying Lutetium nca Lu 177 for the Manufacturing of Clinical Doses for the Phase II STARLITE 2 Study At MSK and Manufacturing Clinical Doses for Telix’s Phase III ZIRCON Trial Businesswire
10-May-2022 Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients Newswire
09-May-2022 Voluntary Improvement Program (VIP) Becomes the First Case for Quality Program Recognized by the FDA Businesswire
09-May-2022 Invacare Reports Results for First Quarter 2022 Businesswire
09-May-2022 Harris Williams Advises STAXS® on its Pending Sale to Franz Haniel & Cie. GmbH Businesswire
09-May-2022 Verastem Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress Businesswire
09-May-2022 Arcus Biosciences Reports First Quarter 2022 Financial Results and Provides a Pipeline Update, Including from the Third Interim Analysis for the ARC-7 Study Businesswire
09-May-2022 Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2022 With Webcast and Conference Call Today at 4:30 p.m. ET Businesswire
09-May-2022 Ocular Therapeutix™ Reports First Quarter 2022 Financial Results and Business Update Businesswire
09-May-2022 Arcturus Therapeutics Announces First Quarter 2022 Financial Update and Pipeline Progress Businesswire
09-May-2022 4th Annual Mental Health Policy Forum Convenes National Policymakers and Advocates on Capitol Hill Businesswire